John Prendergast
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
John Prendergast
Non-Executive Director, Non-Executive Chairman / Recce Pharmaceuticals
Dr John Prendergast has international experience in commercialising pharmaceuticals for global markets, particularly in the USA. He is chair and co-founder of Palatin Technologies (NYSE: PTN), a US biotechnology company; lead director of Heat Biologics (NASDAQ: HTBX); and co-founder/executive chair of Nejo. Dr Prendergast also held previous US biotechnology board positions particularly as lead director of MediciNova (Nasdaq:MNOV) and Osaka Securities Exchange (#4875) and co-founder/lead director of Avigen. Prior to a career in commercialising pharmaceutical technologies, Dr Prendergast was managing director of Paramount Capital Investments and The Castle Group. Dr Prendergast was also a member of the advisory board of the Institute for the Biotechnology of Infectious Diseases (IBID) at the University of Technology Sydney, now called the ithree Institute.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1030th | Recce Pharmaceuticals | -21% | 26% |
| 1171st | Raptis Group | -30% | -20% |
| 1295th | TALI Digital | -38% | -39% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 875th |  | Recce Pharmaceuticals | $4.4m |
| 1023rd | | Rightcrowd | $805k |
| 1024th | | TALI Digital | $784k |
| 1026th | | Raptis Group | $778k |
| 1027th |  | Bingo Industries | $761k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, Non-Executive Chairman, Recce Pharmaceuticals | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, Non-Executive Chairman, Recce Pharmaceuticals | 24 Aug 2020 |
